Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR7280 in Controlled Ovarian Hyperstimulation
NCT05082233Phase 2Completed
- Sponsor
- Hengrui
- Start
- Mar 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SHR7280 in infertility, sponsored by Hengrui. Started Mar 2022; status: completed.
02
Drugs
SHR7280
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05082233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05082233.